PREGNANCY AND DELIVERY MANAGEMENT OF WOMEN WITH AORTA AND AORTIC VALVE PATHOLOGY
https://doi.org/10.15829/1560-4071-2017-2-80-86
Abstract
Aim. To analyze the specifics of clinical course of pregnancy, delivery and postnatal period in women with disorders of aortic valve (AV) and aorta.
Material and methods. During the period from January 2012 to December 2014, under conditions of specialized perinatal center of FSBI Almazov Center in Saint-Petersburg, into prospective cohort study, 56 patients included, with structural pathology of aorta and AV. Mean age 29±4,5 y.o. (18-38 y.o.). All patients underwent echocardiographic study (EchoCG) on Vivid 7 GE equipment by standard protocol. The level of N-terminal brain natriuretic peptide (NT-proBNP) was measured by electrochemiluminiscent analyzer Cobas e411 (Roche, Swiss) at 34±6 week of pregnancy.
Results. The most common pathology in the analyzed group were aortic stenosis and aortic coarctation. The main cause of AV pathology was inborn defect (IHD) — bicuspid AV (BAV). Complications in cardiovascular functioning developed in 9 cases (16%) and were related to ventricular rhythm disorders of high grades and signs of heart failure with need of medication treatment (10,7%, n=6). Level of NT-proBNP was higher than 125 pg/mL in 12 patients (21,4%) and its mean value was 330,3±54,7 pg/mL; in women with increased NT-proBNP complications in cardiovascular system developed 3 times more often. In 25 patients (44,6%) various obstetric complications were found, mostly in the 3rd trimester of pregnancy. Regardless the clinically significant cardial pathology, women delivered in mature term, 38,6±1,5 weeks. After delivery there were no cases of heart failure progression or other cardiovascular complications development.
Conclusion. For women with aortic and AV pathology there is benign prognosis of pregnancy and delivery taken they are managed in specialized centers.
About the Authors
O. B. Irtyuga
Federal Almazov North-West Medical Research Centre of the Ministry of Health, Saint-Petersburg
Russian Federation
Russian Federation
K. O. Mgdesyan
Federal Almazov North-West Medical Research Centre of the Ministry of Health, Saint-Petersburg
Russian Federation
Russian Federation
O. M. Moiseeva
Federal Almazov North-West Medical Research Centre of the Ministry of Health, Saint-Petersburg
Russian Federation
Russian Federation
References
1. Stryuk RI, Bakalov SA, Bunin YA, et al. Russian Guidelines on the diagnostic and management of cardiovascular diseases during pregnancy. Russ J Cardiol 2013; 4: 1-102. Russian (Стрюк Р.И., Бакалов С.А., Бунин Ю.А. и др. Диагностика и лечение сердечно-сосудистых заболеваний при беременности. Российские рекомендации. Российский кардиологический журнал 2013; 4: 1-102).
2. Drenthen W, Boersma E, Balci A, et al. Predictors of pregnancy complications in women with congenital heart disease Eur Heart J. 2010 Sep; 31(17): 2124-32.
3. Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, et al. ESC Committee for Practice Guidelines. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011; 32(24): 3147- 397. Doi:10.1093/eurheartj/ehr218.
4. van Hagen IM, Boersma E, Johnson MR, et al. Global cardiac risk assessment in the Registry Of Pregnancy And Cardiac disease: results of a registry from the European Society of Cardiology. Eur J Heart Fail. 2016; 18(5): 523-33. doi: 10.1002/ejhf.501.
5. Bons LR, Roos-Hesselink JW. Aortic disease and pregnancy. Curr Opin Cardiol. 2016; 31(6): 611-7.
6. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-63.
7. Yap SC, Drenthen W, Pieper PG, et al: Risk of complications during pregnancy in women with congenital aortic stenosis. Int J Cardiol 2008; 126: 240-6.
8. Tanous D, Siu SC, Mason J, et al. B-type natriuretic peptide in pregnant women with heart disease. J Am Coll Cardiol. 2010; 56(15): 1247-53. doi: 10.1016/j.jacc.2010.02.076.
9. Kampman MA, Balci A, van Veldhuisen DJ, et al. N-terminal pro-B-type natriuretic peptide predicts cardiovascular complications in pregnant womenwith congenital heart disease. Eur Heart J. 2014; 35(11): 708-15. doi: 10.1093/eurheartj/eht526.
10. Martins LC, Freire CM, Capuruçu CA, et al. Risk Prediction of Cardiovascular Complications in Pregnant Women With Heart Disease. Arq Bras Cardiol. 2016; 106(4): 289-96. doi: 10.5935/abc.20160028.
11. Pillutla P, Nguyen T, Markovic D, et al. Cardiovascular and Neonatal Outcomes in Pregnant Women With High-Risk Congenital Heart Disease. Am J Cardiol. 2016; 117(10): 1672-7. doi: 10.1016/j.amjcard.2016.02.045.
12. Roos-Hesselink JW, Stein JI. Pregnancy and Cardiac Disease. Rev Esp Cardiol. 2016. doi: 10.1016/j.rec.2016.08.002.
13. Meidahl Petersen K, Jimenez-Solem E, Andersen JT, et al. Beta-blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide populationbased cohort study, BMJ Open (2012) 2.
14. Ertekin E, van Hagen IM, Salam AM, et al. Ventricular tachyarrhythmia during pregnancy in women with heart disease: Data from the ROPAC, a registry from the European Society of Cardiology. Int J Cardiol. 2016; 220: 131-6. doi: 10.1016/j.ijcard.2016.06.061.
15. Beirer M, Banke IJ, Münzel D, et al. Emergency cesarean section due to acute aortic dissection type A (Debakey I) without Marfan syndrome: a case report and review of the literature. J Emerg Med. 2014; 46(1): e13-7.
16. Ladouceur M, Benoit L, Radojevic J, et al. Pregnancy outcomes in patients with pulmonary arterial hypertension associated with congenital heart disease. Heart. 2016 Aug 10. doi: 10.1136/heartjnl-2016-310003.
17. Dadlez NM, Brubaker SG, Simpson LL, et al. Impact of change in delivery practice on neonatal and maternal outcomes in cases of significant congenital heart disease. Congenit Heart Dis. 2014; 9(5): 368-72.
Review
For citations:
Irtyuga O.B., Mgdesyan K.O., Moiseeva O.M. PREGNANCY AND DELIVERY MANAGEMENT OF WOMEN WITH AORTA AND AORTIC VALVE PATHOLOGY. Russian Journal of Cardiology. 2017;(2):80-86. (In Russ.) https://doi.org/10.15829/1560-4071-2017-2-80-86
Views:
4925
Email this article 